K
Koichi Asanuma
Researcher at Sapporo Medical University
Publications - 45
Citations - 1414
Koichi Asanuma is an academic researcher from Sapporo Medical University. The author has contributed to research in topics: Survivin & Gene expression. The author has an hindex of 19, co-authored 41 publications receiving 1342 citations.
Papers
More filters
Journal ArticleDOI
Survivin as a radioresistance factor in pancreatic cancer.
Koichi Asanuma,Ryosuke Moriai,Tomomi Yajima,Atsuhito Yagihashi,Mikako Yamada,Daisuke Kobayashi,Naoki Watanabe +6 more
TL;DR: In this article, the authors examined whether survivin acts as a constitutive and inducible radioresistance factor in pancreatic cancer cells, and they found an inverse relationship between survivin mRNA expression and radiosensitivity.
Journal ArticleDOI
Detection of anti-livin antibody in gastrointestinal cancer patients.
Atsuhito Yagihashi,Koichi Asanuma,Naoki Tsuji,Toshihiko Torigoe,Noriyuki Sato,Koichi Hirata,Naoki Watanabe +6 more
TL;DR: Livin mRNA expression in gastrointestinal cancer cell lines and the prevalence of antibody responses against livin in patients with various gastrointestinal cancers are examined.
Journal ArticleDOI
A role for survivin in radioresistance of pancreatic cancer cells.
Koichi Asanuma,Daisuke Kobayashi,Daisuke Furuya,Naoki Tsuji,Atsuhito Yagihashi,Naoki Watanabe +5 more
TL;DR: Using gene‐transduced pancreatic cancer cells, results indicate that survivin expression directly down‐regulates radiosensitivity.
Journal ArticleDOI
Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.
TL;DR: Correlation between survivin and human telomerase reverse transcriptase (hTERT) expression was observed in colon cancer tissues, and overexpression of survivin enhanced telomersase activity by up-regulation of hTERT expression in LS180 human colon cancer cells.
Journal ArticleDOI
Detection of autoantibodies to survivin and livin in sera from patients with breast cancer
Atsuhito Yagihashi,Tohsei Ohmura,Koichi Asanuma,Daisuke Kobayashi,Naoki Tsuji,Toshihiko Torigoe,Noriyuki Sato,Koichi Hirata,Naoki Watanabe +8 more
TL;DR: Anti-livin antibodies were detected in sera from breast cancer patients by an anti- Livin ELISA using full-length recombinant livin protein, suggesting livin may act as a major cancer antigen in Breast cancer patients.